Biblio Discovery — Demo Discovery Service

385 hasil

Menampilkan 1–20 · 0,36 detik · RSS

Jurnal

Cancer Biology & Therapy

Scopus

ISSN 1538-4047 · Taylor & Francis Group · 385 artikel di indeks

  1. Artikel Jurnal

    Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression

    Chunyan Wang; Hongyan Zhang; Chaonan Guan dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background CD276/B7-H3 is an immune checkpoint molecule often overexpressed in cancers, representing a potential therapeutic target. The underlying mechanisms for CD276 upregulation remain unclear. This study investigates how glutamine metabolism affects CD276 protein stability and esophageal…

  2. Artikel Jurnal

    Identification of coilin in bone marrow as a potential neuroblastoma tumor progression marker transcriptionally regulated by MYCN

    Zhixia Yue; Lan Li; Shuguang Liu dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background Current risk stratification for neuroblastoma (NB) relies on limited markers like MYCN amplification. Coilin, a key Cajal body component, regulates cellular processes. This study investigates whether coilin expression in bone marrow (BM) serves as a predictive biomarker for NB…

  3. Artikel Jurnal

    Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma

    Gongcheng Wang; Zhenzhen Li; Siyu Tan dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Esophageal cancer is one of the most prevalent malignant tumors of the digestive tract, with esophageal squamous cell carcinoma (ESCC) as its main histological type. In recent years, immunotherapeutic regimens centered on immune checkpoint inhibitors (ICIs) have achieved remarkable efficacy in…

  4. Artikel Jurnal

    ENPP3 drives ccRCC progression by cGAMP hydrolysis and STING–IFN suppression

    Jiaxing Ma; Yayun Wu; Guangzheng Lin dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Objective Clear-cell renal cell carcinoma (ccRCC) is an immune-desert tumor. This study investigates the role of ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) as a potential therapeutic target and immune-checkpoint enzyme in ccRCC.Methods ENPP3 expression and its link to hypoxia and…

  5. Artikel Jurnal

    Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)

    Li Zhou; Jin Ke; Shanlan Zhang dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer with high brain metastatic (BM) potential. Tumor-derived exosomes are implicated as key modulators during the formation of the pre-metastatic niche (PMN). However, the regulation of TNBC-BM-derived exosomes on…

  6. Artikel Jurnal

    Fibroblast-associated TPM2 links cell-matrix remodeling to EMT-Notch signaling and gemcitabine resistance in intrahepatic cholangiocarcinoma

    Yingjiao Zhu; Zhibin Qiao; Zhuhong Chen dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background Intrahepatic cholangiocarcinoma (ICC) is an aggressive liver malignancy with heterogeneous responses to gemcitabine-based chemotherapy. The cellular and microenvironmental programs associated with the gemcitabine response remain incompletely understood. This study aimed to identify tumor…

  7. Artikel Jurnal

    Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progression

    Jinman Zhong; Yanmeng Deng; Xingru Qin dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background Long noncoding RNAs (lncRNAs) have significant impacts on the occurrence and development of many cancers. However, their effects and mechanisms on prostate cancer (PCa) remain largely unknown. The study was to explore the influence of lncSPATA8-AS1 on PCa and its molecular mechanism of…

  8. Artikel Jurnal

    ABHD17C regulates the efficacy of lenvatinib in suppressing hepatocellular carcinoma

    Linpei Wang; Jiawei Wang; Xiaoqiu Ma dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction Lenvatinib is a first-line therapy for hepatocellular carcinoma (HCC), but its clinical efficacy is limited by drug resistance. ABHD17C, a depalmitoylation enzyme involved in HCC progression, has not been investigated in lenvatinib response. This study aimed to determine whether…

  9. Artikel Jurnal

    Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy

    Allison Staton; Melissa Abel; William D. Figg

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Loss of the PTEN tumor suppressor gene is a common molecular feature in advanced prostate cancer and is associated with activation of the PI3K/AKT signaling pathway, which controls cell growth and survival. Despite major advances in the treatment of metastatic castration-sensitive prostate cancer…

  10. Artikel Jurnal

    STARD10 promotes progression of HER2+ breast cancer and intracellular lipid metabolism via the cAMP/PKA/CREB1 signaling axis

    Siyao Liu; Jing Gao; Yichen Niu dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background Although targeted therapies have improved clinical outcomes, HER2+ breast cancer remains a significant clinical challenge due to its aggressive behavior and unfavorable prognosis. Emerging evidence indicates that dysregulated lipid metabolism plays a critical role in tumorigenesis and…

  11. Artikel Jurnal

    CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D-driven chronic myelomonocytic leukemia

    Yuchen Li; Xu Jiang; Yinfeng Gu dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background A subset of patients with chronic myelomonocytic leukemia (CMML) carries NRAS mutations, which are associated with shorter overall survival and an increased risk of transformation to acute myeloid leukemia. However, the effects of NRAS mutations on the bone marrow microenvironment (BME)…

  12. Artikel Jurnal

    ULK1's role in cancer progression and its emerging therapeutic potential

    Jack D. Webb; Trevor G. Shepherd

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Macroautophagy (autophagy) enables cellular stress adaptation by degrading damaged components; ULK1, a serine/threonine kinase, initiates this process in response to nutrient and energy cues. While autophagy is well studied, few investigations have directly tested ULK1 in cancer progression…

  13. Artikel Jurnal

    Retinol dehydrogenase 11 promotes prostate cancer progression through upregulation of tropomyosin receptor kinase A

    Shenghan Wang; Shuyu Zhang; Zekun Xin dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Objective To clarify the clinical significance and biological function of retinol dehydrogenase-11 (RDH11) in prostate cancer (PCa) and to elucidate the downstream signaling mechanism through which it drives tumor progression.Methods Public and in-house transcriptomic data were mined to compare…

  14. Artikel Jurnal

    Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis

    Chenguang Liu; Shiyang Liu; Zonghong Lu dkk.

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background Docetaxel (DTX) is one of the commonly used chemotherapeutic agents for breast cancer. Cuproptosis, a newly defined form of cell death, significantly influences tumor progression. This study aims to identify cuproptosis-related long non-coding RNAs (lncRNAs) involved in regulating the…

  15. Artikel Jurnal

    Advances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles

    Yu-Nan Man; Mao-Lin He

    Cancer Biology & Therapy, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    SEC61G, the γ subunit of the Sec61 translocon, has long been regarded as a passenger co-amplification target of EGFR on chromosome 7p11.2. Recent studies have revealed its independent oncogenic functions across multiple cancers. This review proposes a mechanism-based classification of SEC61G…